Study on Optic Neuropathy in Mice Lacking NF-κB p50
Author Information
Author(s): Nakamura-Yanagidaira Tomoko, Takahashi Yasuko, Sano Kenji, Murata Toshinori, Hayashi Takuma
Primary Institution: Shinshu University Graduate School of Medicine
Hypothesis
The study aims to elucidate the signal cascade mediating spontaneous optic neuropathy in NF-κB p50-deficient mice as a model of normal tension glaucoma.
Conclusion
Chronic administration of tacrolimus significantly reduces spontaneous optic neuropathy in p50-deficient mice.
Supporting Evidence
- NF-κB-inducible Bax and activated caspase 3 were expressed in the retina of p50-deficient mice.
- Tacrolimus significantly protected retinal ganglion cells from NMDA-induced neurotoxicity.
- Chronic administration of tacrolimus reduced spontaneous RGC death and optic nerve degeneration.
Takeaway
Researchers found that a medicine called tacrolimus can help protect the eyes of mice that have a condition similar to a type of glaucoma.
Methodology
The study involved western blotting, luciferase reporter assays, and histopathological studies on p50-deficient and wild-type mice, as well as cultured retinal ganglion cells.
Limitations
The study primarily uses a mouse model, which may not fully replicate human conditions.
Participant Demographics
Mice aged 3 weeks to 10 months, including both wild-type and p50-deficient strains.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.01
Want to read the original?
Access the complete publication on the publisher's website